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Correction of Nasolabial Folds Using Hyaluronic 
Acid Filler Plus Subcutaneous Injections of 
Carbon Dioxide
Sir:
We read with great interest the article by Joo et al. entitled “A Randomized Clinical Trial to Evaluate 
the Efficacy and Safety of Lidocaine-Containing Mono-
phasic Hyaluronic Acid Filler for Nasolabial Folds.”1 The 
goal of this clinical trial was to compare the efficacy and 
safety between two different hyaluronic acid fillers con-
taining 0.3% lidocaine for the correction of nasolabial 
folds. Clinical efficacy and safety were assessed by blinded 
investigators, independent expert panels, and patients 
based on the Wrinkle Severity Rating Scale and the 
Global Aesthetic Improvement Scale at weeks 8, 16, and 
24 after the injection. This randomized, double-blind, 
clinical trial showed good efficacy for both products in 
terms of wrinkle severity improvement and injection 
pain reduction.
A prominent nasolabial fold is a cosmetic problem. 
Currently, numerous therapeutic modalities are avail-
able for pronounced nasolabial folds, with variable effi-
cacy. Botulinum toxin, hyaluronic acid filler, subcision 
technique, growth factor concentrate, and platelet-rich 
plasma are only some examples.2–4
The main application of hyaluronic acid filling, in 
aesthetic medicine, is the augmentation of soft tissues. 
The carbon dioxide therapy, instead, improves quality and 
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Reply: Avulsion Thighplasty: Technique 
Overview and 6-Year Experience
Sir:
We applaud Drs. Razzano et al. for bridging the 
gap between cosmetic and reconstructive surgery with 
their observation that a thigh lift procedure may com-
promise a potential future reconstructive donor site, 
and that this possible future loss of reconstructive 
option should be included in the preoperative consent 
form. As the authors noted, the loss of potential future 
reconstructive sites has already been debated in the 
abdomen, where an abdominoplasty can void the first-
choice reconstructive options.
Although there have been no case reports to our 
knowledge of the use of the medial thigh tissues as a 
transverse upper gracilis flap or a profunda artery per-
forator flap after a thigh lift to perform a reconstructive 
procedure, the point of potentially losing a donor site is 
interesting, especially in a litigious American society. 
It is also worth noting that the thigh lift procedure1 
predates the first successful free skin flap performed 
in a human,2 and although an aesthetic procedure can 
potentially preclude a future reconstructive endeavor 
in the same body area, the inverse is also true.
Drs. Razzano et al. suggest that the posterior per-
forating vessels of the profunda artery perforator flap 
may be preserved after avulsion thighplasty and that 
it could possibly still be a donor source, whereas the 
transverse upper gracilis flap is less likely a valid source, 
as the perforating vessels fall directly over the skin 
resection pattern for avulsion thighplasty.
We have no experience dissecting these perforators 
in either case after thigh lift, but theoretically, both vas-
cular pedicles and their perforators would remain intact 
after an avulsion thighplasty, as the lymphatics and blood 
vessels are largely undamaged by the technique; however, 
we do not know how widely these vessels perfuse their 
newly overlying skin after resection of the redundant skin.
Two other major factors that might still restrict the 
use of these flaps after an avulsion thighplasty would 
be whether there would be enough skin laxity after 
the thigh lift to close a new donor site, and whether 
the remaining pedicles would perfuse enough tissue 
across the surgical scars from the avulsion thighplasty 
to make them reliable options. The timing to poten-
tially  reperfuse the overlying skin is also not known and 
to our knowledge has not been studied.
Currently, there are only theoretical concerns that 
a free flap from the medial thigh cannot be performed 
after an avulsion thighplasty. This is certainly an interest-
ing area for future research and we would like to thank 
Drs. Razzano et al. for stimulating the conversation.
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A Randomized Clinical Trial to Evaluate the 
Efficacy and Safety of Lidocaine-Containing 
Monophasic Hyaluronic Acid Filler for 
Nasolabial Folds
Sir:
We read with great interest the article by Hong Jin Joo et al.1 entitled “A Randomized Clinical Trial 
to Evaluate the Efficacy and Safety of Lidocaine-Con-
taining Monophasic Hyaluronic Acid Filler for Nasola-
bial Folds.” Because of the high standards of the global 
filler market that demands constant material improve-
ment, this article highlights the need for development 
of safe hyaluronic acid fillers.
However, one of the two parameters evaluated and 
compared in this study is clinical efficacy of two different 
(monophasic and biphasic) hyaluronic acids, Neuramis 
Deep Lidocaine and Restylane Perlane-L. Interestingly, vis-
iting Restylane’s site (Galderma Laboratories, Fort Worth, 
Texas),2 in a section entitled Monophasic Biphasic Seman-
tics, it is concluded that “The terms monophasic or bipha-
sic have no relevance at all to the clinical efficacy of fillers 
and are a gross misrepresentation of the truth.” We feel 
that this contradiction is in direct conflict with this impor-
tant study’s concept. We also believe that the authors need 
to clarify more specifically how the monophasic or bipha-
sic nature of hyaluronic acid interacts with clinical efficacy. 
Like other authors, we support that biphasic hyaluronic 
acid is a myth and that discrimination of hyaluronic acid 
fillers as biphasic or monophasic is proved scientifically 
incorrect and should therefore be avoided.3
We believe that further research needs to be per-
formed to clarify the true relation between terms such 
as clinical efficacy and hyaluronic acid components. 
Until then, studies such as this one need to be carefully 
filtered to avoid misunderstandings that might lead to 
confusion. Plastic surgery research needs a solid and 
clear base of data to move on.
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elasticity of the dermis and increases the oxygen release to 
the tissue through an enhancing of the Bohr effect.
In a recent study, we compared hyaluronic acid 
filler and hyaluronic acid filler plus subcutaneous 
injections of carbon dioxide for cosmetic correction of 
nasolabial folds.5 Forty healthy female patients received 
a blinded and randomized treatment on nasolabial 
folds for cosmetic correction of the nasolabial folds. 
The results were evaluated by two blinded plastic sur-
geons after the implant (1 week and 4 and 6 months) 
using the Global Aesthetic Improvement Scale, and at 
the same time, each patient was asked to express her 
opinion about the cosmetic result.
Any long-term adverse reaction was reported. The 
blinded evaluation at 4 and 6 months from implanta-
tion showed in all patients maintenance of a good cos-
metic result, higher for the side treated with carbon 
dioxide therapy plus hyaluronic acid. We think that 
this combination therapy should be taken into consid-
eration when the treatment of moderate and severe 
nasolabial folds is approached, because of its easy 
application and excellent results.
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